United States News Todas as matérias

Circle Internet Group (NASDAQ:CRCL) experienced its most volatile trading session on record Tuesday, with shares plunging as much as 20% following leaked reports regarding the latest draft of the Digital Asset Market Clarity Act.

Apple (NASDAQ:AAPL) today announced a significant expansion of its advertising ecosystem, confirming that paid search ads will debut on Apple Maps in the United States and Canada this summer.

Energy Focus (NASDAQ:EFOI) today reported its financial results for the fourth quarter and full year ended December 31, 2025, reflecting a period of narrowed losses and continued focus on high-specification lighting solutions.

Trian Fund Management and General Catalyst Group Management today announced a definitive amendment to their merger agreement with Janus Henderson Group (NYSE:JHG), raising the acquisition price to $52 per share in cash.

Sanara MedTech (NASDAQ:SMTI) today announced its financial results for the fourth quarter and full year ended December 31, 2025, marking the first time the company has surpassed the $100 million annual revenue threshold.

Perma-Fix Environmental Services (NASDAQ:PESI) today reported financial results for the full year ended December 31, 2025, detailing a year of strategic capacity expansion and a significant buildup in high-margin service demand.

Neurogene (NASDAQ:NGNE) today reported financial results for the fourth quarter and full year ended December 31, 2025, delivering a "beat" against Wall Street’s bottom-line expectations.

LENZ Therapeutics (NASDAQ:LENZ) today reported its financial results for the fourth quarter and full year ended December 31, 2025, providing the first comprehensive look at the commercial performance of VIZZ® (aceclidine 1.44%).

Heidmar Maritime Holdings (NASDAQ:HMR) today reported its financial results for the fourth quarter and full year ended December 31, 2025, highlighting a period of rapid institutional scaling.

Ocugen (NASDAQ:OCGN) today announced positive 12-month results from its Phase 2 ArMaDa clinical trial evaluating OCU410 (AAV-hRORA), a modifier gene therapy for the treatment of Geographic Atrophy (GA) secondary to dry Age-Related Macular Degeneration (dAMD).

NRx Pharmaceuticals (NASDAQ:NRXP) today reported its financial results and operational milestones for the full year ended December 31, 2025, highlighting a successful restructuring of its balance sheet and the transition into a revenue-generating entity.

Concentrix (NASDAQ:CNXC) today reported its financial results for the fiscal first quarter ended February 28, 2026, demonstrating steady top-line expansion and a continued commitment to shareholder returns.

Core & Main (NYSE:CNM) today reported financial results for the fourth quarter and fiscal year ended February 1, 2026, showcasing a year of disciplined margin management and robust cash generation.

Fennec Pharmaceuticals (NASDAQ:FENC) today reported its financial results for the fourth quarter and full year ended December 31, 2025, highlighting a year of aggressive commercial scaling and a total recapitalization of the company’s balance sheet.

Achieve Life Sciences (NASDAQ:ACHV) today reported its financial results for the fourth quarter and full year ended December 31, 2025, alongside a series of transformative regulatory and operational updates for its lead smoking cessation candidate, cytisinicline.

Karyopharm Therapeutics (NASDAQ:KPTI) today announced topline results from its global Phase 3 SENTRY clinical trial (n=353) evaluating the XPO1 inhibitor selinexor in combination with ruxolitinib (Jakafi®) for the frontline treatment of patients with myelofibrosis.

LightInTheBox Holding (NYSE:LITB) today announced its unaudited financial results for the fourth quarter and full year ended December 31, 2025, marking a definitive shift from high-volume scaling to high-margin profitability.

VersaBank (NASDAQ:VBNK) today announced it has reached a definitive agreement to sell the assets associated with its sole U.S. retail branch in Holdingford, Minnesota, to Stearns Bank National Association.

The Buckle (NYSE:BKE) today announced that its Board of Directors has authorized a quarterly cash dividend of $0.35 per share.

BioNTech (NASDAQ:BNTX) announced today its comprehensive participation in the European Lung Cancer Congress (ELCC) 2026, where the company will present updated data across its diversified lung cancer portfolio.

UTStarcom (NASDAQ:UTSI) today reported its unaudited financial results for the six months and full year ended December 31, 2025, revealing a challenging fiscal year defined by a significant contraction in its primary geographic markets.

Radiopharm Theranostics (NASDAQ:RADX) today released a highly encouraging second interim data update from its ongoing U.S. Phase 2b clinical trial evaluating RAD 101, a novel FASN-targeting small-molecule imaging agent.

G. Willi-Food International (NASDAQ:WILC) today announced its financial results for the fiscal year ended December 31, 2025, revealing a year of significant margin expansion and record bottom-line performance.

Borr Drilling (NYSE:BORR) announced today that it has entered into definitive agreements to acquire five premium jack-up rigs from Fontis Finance for a total purchase price of $287 million.